Mark Strobeck - 01 Jul 2025 Form 4/A - Amendment Insider Report for ROCKWELL MEDICAL, INC. (RMTI)

Signature
/s/ Megan Timmins, Attorney-in-fact for Mark Strobeck
Issuer symbol
RMTI
Transactions as of
01 Jul 2025
Net transactions value
-$5,679
Form type
4/A - Amendment
Filing time
03 Jul 2025, 13:26:18 UTC
Date Of Original Report
02 Jul 2025
Previous filing
21 May 2025
Next filing
01 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Strobeck Mark President and CEO, Director 30142 WIXOM ROAD, WIXOM /s/ Megan Timmins, Attorney-in-fact for Mark Strobeck 03 Jul 2025 0001599219

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMTI Common Stock Sale $5,679 -6,926 -2% $0.8200 337,752 01 Jul 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024 in multiple trades at prices ranging from $0.81 to $0.84. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

This form is being amended to check the required box for sales pursuant to a Rule 10b5-1 Plan.